BiotechTube
Home/Mission Therapeutics/Dr Anker Lundemose
DA

Dr Anker Lundemose

Executive Director

Mission Therapeutics

Therapeutic Areas

Parkinson's DiseaseNeurodegenerative DiseasesHeart DiseaseKidney DiseaseFibrosisMitochondrial Diseases

Mission Therapeutics Pipeline

DrugIndicationPhase
MTX325Parkinson's DiseasePhase 1b
MTX652Acute Kidney Injury (AKI) / OtherPre-clinical/Phase 1